Title: The Impact of the COVID-19 Surge After the End of China's Zero-COVID Policy on the
Health-Related Quality of Life of IBD Patients
Version: 3 Date: 13 Aug 2024
Reviewer's report:
Thank you for addressing the major revisions to your manuscript. I believe it is now in a much
better state and merits publication. However, I suggest a few minor changes for further clarity
and completeness:
1. As your secondary outcome is defined as “the factors related to COVID-19 infection,” it is
essential to provide detailed information about these factors. Alternatively, consider changing
this to the symptom distribution among IBD patients during the COVID-19 pandemic for clearer
understanding and alignment with the data presented.
2. Please add a limitation to your study addressing the lack of disease severity information in
the study cohort. This will provide readers with a clearer understanding of the study's context
and the potential implications of this limitation.
3. I recommend revising the beginning of your discussion section to focus more on the study
outcomes rather than comparing COVID-19 policies in different countries. This comparison
could be moved to a later part of the discussion, allowing the primary findings of your study to
take precedence in this section.
Title: The Impact of the COVID-19 Surge After the End of China's Zero-COVID Policy on the
Health-Related Quality of Life of IBD Patients
Version: 3 Date: 13 Aug 2024
Reviewer's report:
Thank you for addressing the major revisions to your manuscript. I believe it is now in a much
better state and merits publication. However, I suggest a few minor changes for further clarity
and completeness:
1. As your secondary outcome is defined as “the factors related to COVID-19 infection,” it is
essential to provide detailed information about these factors. Alternatively, consider changing
this to the symptom distribution among IBD patients during the COVID-19 pandemic for clearer
understanding and alignment with the data presented.
2. Please add a limitation to your study addressing the lack of disease severity information in
the study cohort. This will provide readers with a clearer understanding of the study's context
and the potential implications of this limitation.
3. I recommend revising the beginning of your discussion section to focus more on the study
outcomes rather than comparing COVID-19 policies in different countries. This comparison
could be moved to a later part of the discussion, allowing the primary findings of your study to
take precedence in this section.
Please review this paper.
user
Title: The Impact of the COVID-19 Surge After the End of China's Zero-COVID Policy on the
Health-Related Quality of Life of IBD Patients
Version: 3 Date: 13 Aug 2024
Reviewer's report:
Thank you for addressing the major revisions to your manuscript. I believe it is now in a much
better state and merits publication. However, I suggest a few minor changes for further clarity
and completeness:
1. As your secondary outcome is defined as “the factors related to COVID-19 infection,” it is
essential to provide detailed information about these factors. Alternatively, consider changing
this to the symptom distribution among IBD patients during the COVID-19 pandemic for clearer
understanding and alignment with the data presented.
2. Please add a limitation to your study addressing the lack of disease severity information in
the study cohort. This will provide readers with a clearer understanding of the study's context
and the potential implications of this limitation.
3. I recommend revising the beginning of your discussion section to focus more on the study
outcomes rather than comparing COVID-19 policies in different countries. This comparison
could be moved to a later part of the discussion, allowing the primary findings of your study to
take precedence in this section.
assistant